June 21, 2022 Update: The Court approved the distribution, and the payments are scheduled to be issued on July 6, 2022. If you do not receive your expected payment by July 22, 2022, please send an email to info@thalomidrevlimidlitigation.com to request a re-issue.

IF YOU PURCHASED THE PRESCRIPTION DRUGS THALOMID OR REVLIMID, YOUR RIGHTS MAY BE AFFECTED, AND YOU COULD GET A PAYMENT FROM A CLASS ACTION SETTLEMENT.

In March 2020, a new settlement was reached with Celgene Corporation (“Celgene”) in a class action lawsuit about whether Celgene acted unlawfully to keep generic versions of Thalomid and Revlimid off the market. Celgene denies all of the claims in the lawsuit. The Plaintiffs and Celgene have agreed to the settlement to avoid the cost and risk of a trial. 

You may be a Settlement Class Member if you were:

Celgene agreed to settle the lawsuit for $34 million.

You may be included in this settlement if you are a Third-Party Payor ("TPP") or consumer that paid for all or some of the purchase price of Thalomid or Revlimid in California, the District of Columbia, Florida, Kansas, Maine, Massachusetts, Michigan, Nebraska, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, or Tennessee any time before May 20, 2020. 

YOUR LEGAL RIGHTS AND OPTIONS IN THIS SETTLEMENT:

SUBMIT A CLAIM FORM:

October 15, 2020

Unless you already submitted a claim, this is the only way you will receive any payment from the settlement with Celgene. If you submitted a claim to participate in the 2019 class action settlement with Celgene, you do not need to, but you can, submit a supplemental claim for additional purchases made after  August 1, 2019.  You will also give up the right to sue Celgene in a separate lawsuit about the claims this settlement resolves.

EXCLUSION DEADLINE: September 15, 2020

If you decide to exclude yourself or your entity, you will keep the right to sue Celgene in a separate lawsuit about the claims this settlement resolves, but you give up the right to get a payment from this settlement. 

This is the only option that allows you to sue, continue to sue, or be part of another lawsuit against Celgene related to the legal claims in this case. 

 

OBJECTION DEADLINE: September 15, 2020

 

If you want to remain a Settlement Class Member, you may object to it by writing to the Court about why you don't like the settlement.

 

FAIRNESS HEARING: 

You may object to the settlement and ask the Court for permission to speak at the Fairness Hearing about your objection.

 

Do Nothing

 

 

If you are a Settlement Class Member, you are automatically part of the settlement. If you do nothing, you will not get a payment from this settlement unless you previously submitted a Claim Form.  You will give up the right to sue, continue to sue, or be part of another lawsuit against Celgene for any claim made in this lawsuit or released by the Settlement Agreement.

 

If you submitted a claim in 2019, your claim will automatically be evaluated for eligibility to receive a payment if the proposed settlement is approved.

 

Your rights are affected whether you act or do not act.  Therefore, you should read the Notice carefully.